Israel's BrainStorm Gets Speeded Review Of Rare ALS Treatment
This article was originally published in PharmAsia News
BrainStorm Cell Therapeutics said its stem cell treatment for amyotrophic lateral sclerosis has received U.S. FDA clearance for special review
You may also be interested in...
Work and movement-related restrictions are affecting the ability of companies to provide a timely response to questions relating to their prequalification dossiers.
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.